Most skin cancers are discovered and treated before they spread. Melanoma that has spread to other organs is the most challenging reading.
Standard treatments for basal cell carcinoma and squamous cell carcinoma are safe and effective. small tumors can be surgically removed, removed by scraping tool (scraper) and then burning frozen in liquid nitrogen have been killed or low doses of radiation. The larger tumors are removed surgically.
In the rare cases where basal cell carcinoma or squamous cell cancer began to spread after the skin the tumor is removed surgically and patients treated with chemotherapy and radiation.
The melanoma tumor must be removed surgically preferably before it spreads to the skin to other organs. The surgeon removes the tumor completely, and a safe margin of surrounding tissue. E ‘questionable whether the removal of nearby lymph nodes is useful in some cases. Advanced melanoma can’t be cure by radiotherapy or chemotherapy but it can slow the disease and alleviate symptoms. Chemotherapy sometimes in combination with immunotherapy interferon is generally preferred. If the melanoma spreads to the brain, radiation is used to slow growth and control symptoms.
Immunotherapy is a relatively new cancer treatment designed to attack and kill cancer cells by manipulating the body’s immune system. Some of the most promising developments in the field of immunotherapy have been efforts to cure advanced melanoma. Some researchers are treating advanced cases with vaccines while others use drugs like interferon and interleukin 2 in an effort to stimulate immune cells to attack melanoma cells more aggressively. Genetic manipulation of melanoma tumors may make them more vulnerable to attack by the immune system. Each of these experimental treatment approaches designed to immunize the body of a patient against his own cancer something the body can not produce naturally.
People who have had skin cancer once are at risk of getting it again. Anyone who has dealt with skin cancer of any type must be a medical checkup at least once a year. About 20% of patients with skin cancer experience relapse usually within the first two years after diagnosis.
